LHRH analogues in the treatment of cancer
- 1 September 1989
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 16 (3) , 161-175
- https://doi.org/10.1016/0305-7372(89)90008-x
Abstract
No abstract availableThis publication has 47 references indexed in Scilit:
- Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast CancerNew England Journal of Medicine, 1988
- Advanced male breast cancer treatment with the LH-RH analogue buserelin alone or in combination with the antiandrogen flutamideCancer, 1988
- A comparison of leuprolide with flutamide and leuprolide in previously untreated patients with clinical stage D2: Cancer of the prostate, phase III, Intergroup study-0036European Journal of Cancer and Clinical Oncology, 1987
- Long-acting (depot) D-TRP-6-LHRH(decapeptyl) in human prostate cancer. An Italian multicentric trialEuropean Journal of Cancer and Clinical Oncology, 1987
- Total androgen blockade for metastatic cancer of prostateEuropean Journal of Cancer and Clinical Oncology, 1987
- 49 Long acting LHRH analogue versus LHBH plus cyproterone acetate, versus cyproterone acetate alone in treatment of advanced prostate cancerJournal of Steroid Biochemistry, 1985
- Chapter 21. Luteinizing Hormone Releasing Hormone (LHRH) AnaloguesPublished by Elsevier ,1985
- Absorption from the VaginaDrug Metabolism Reviews, 1983
- Use of analogues of luteinizing hormone-releasing hormone for the treatment of cancerReproduction, 1982
- ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1The Lancet, 1896